Discontinued — last reported Q4 '25
IDEX Health & Science Technologies — Goodwill, Impaired, Accumulated Impairment Loss remained flat by 0.0% to $149.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $149.80M to $149.80M. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests that past acquisitions in this segment have not met performance expectations, indicating potential strategic missteps.
The cumulative reduction in the carrying value of goodwill within the Health and Science Technologies segment due to imp...
Standard impairment tracking metric for segments with significant historical M&A activity.
iex_segment_health_science_technologies_goodwill_impaired_accumulated_impairment_loss| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $149.80M | $149.80M | $149.80M | $149.80M | $149.80M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | +0.0% | +0.0% | +0.0% | +0.0% |